カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の抗レトロウイルスプロテアーゼ阻害剤市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Antiretroviral Protease Inhibitor Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19151）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19151
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：97
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の抗レトロウイルスプロテアーゼ阻害剤市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

抗レトロウイルスプロテアーゼ阻害剤市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の抗レトロウイルスプロテアーゼ阻害剤の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

抗レトロウイルスプロテアーゼ阻害剤市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・セリンプロテアーゼ阻害剤、システインプロテアーゼ阻害剤、アミノペプチダーゼ阻害剤、アスパラギン酸プロテアーゼ阻害剤、メタロプロテアーゼ阻害剤、その他

用途別セグメントは次のように区分されます。
・病院調剤薬局、小売調剤薬局、オンライン調剤薬局、その他

世界の抗レトロウイルスプロテアーゼ阻害剤市場の主要な市場プレーヤーは以下のとおりです。
・Boehringer Ingelheim、Merck、Genentech、AbbVie、Tibotec、Bristol-Myers Squibb

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、抗レトロウイルスプロテアーゼ阻害剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な抗レトロウイルスプロテアーゼ阻害剤メーカーの企業概要、2019年～2022年までの抗レトロウイルスプロテアーゼ阻害剤の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な抗レトロウイルスプロテアーゼ阻害剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別抗レトロウイルスプロテアーゼ阻害剤の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの抗レトロウイルスプロテアーゼ阻害剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での抗レトロウイルスプロテアーゼ阻害剤市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および抗レトロウイルスプロテアーゼ阻害剤の産業チェーンを掲載しています。
・第13、14、15章では、抗レトロウイルスプロテアーゼ阻害剤の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 抗レトロウイルスプロテアーゼ阻害剤の概要
- 種類別分析（2017年vs2021年vs2028年）：セリンプロテアーゼ阻害剤、システインプロテアーゼ阻害剤、アミノペプチダーゼ阻害剤、アスパラギン酸プロテアーゼ阻害剤、メタロプロテアーゼ阻害剤、その他
- 用途別分析（2017年vs2021年vs2028年）：病院調剤薬局、小売調剤薬局、オンライン調剤薬局、その他
- 世界の抗レトロウイルスプロテアーゼ阻害剤市場規模・予測
- 世界の抗レトロウイルスプロテアーゼ阻害剤生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Boehringer Ingelheim、Merck、Genentech、AbbVie、Tibotec、Bristol-Myers Squibb
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：セリンプロテアーゼ阻害剤、システインプロテアーゼ阻害剤、アミノペプチダーゼ阻害剤、アスパラギン酸プロテアーゼ阻害剤、メタロプロテアーゼ阻害剤、その他
・用途別分析2017年-2028年：病院調剤薬局、小売調剤薬局、オンライン調剤薬局、その他
・抗レトロウイルスプロテアーゼ阻害剤の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・抗レトロウイルスプロテアーゼ阻害剤のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・抗レトロウイルスプロテアーゼ阻害剤のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・抗レトロウイルスプロテアーゼ阻害剤の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・抗レトロウイルスプロテアーゼ阻害剤の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Antiretroviral Protease Inhibitor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Antiretroviral Protease Inhibitor market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital Pharmacy accounting for % of the Antiretroviral Protease Inhibitor global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Serine Protease Inhibitors segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Antiretroviral Protease Inhibitor include Boehringer Ingelheim, Merck, Genentech, AbbVie, and Tibotec, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Antiretroviral Protease Inhibitor market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Serine Protease Inhibitors
Cysteine Protease Inhibitors
Amino Peptidase Inhibitor
Aspartic Protease Inhibitors
Metallo-Protease Inhibitors
Others
Market segment by Application can be divided into
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
The key market players for global Antiretroviral Protease Inhibitor market are listed below:
Boehringer Ingelheim
Merck
Genentech
AbbVie
Tibotec
Bristol-Myers Squibb
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antiretroviral Protease Inhibitor product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antiretroviral Protease Inhibitor, with price, sales, revenue and global market share of Antiretroviral Protease Inhibitor from 2019 to 2022.
Chapter 3, the Antiretroviral Protease Inhibitor competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antiretroviral Protease Inhibitor breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Antiretroviral Protease Inhibitor market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Antiretroviral Protease Inhibitor.
Chapter 13, 14, and 15, to describe Antiretroviral Protease Inhibitor sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Antiretroviral Protease Inhibitor Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antiretroviral Protease Inhibitor Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Serine Protease Inhibitors
1.2.3 Cysteine Protease Inhibitors
1.2.4 Amino Peptidase Inhibitor
1.2.5 Aspartic Protease Inhibitors
1.2.6 Metallo-Protease Inhibitors
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Antiretroviral Protease Inhibitor Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Global Antiretroviral Protease Inhibitor Market Size & Forecast
1.4.1 Global Antiretroviral Protease Inhibitor Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Antiretroviral Protease Inhibitor Sales in Volume (2017-2028)
1.4.3 Global Antiretroviral Protease Inhibitor Price (2017-2028)
1.5 Global Antiretroviral Protease Inhibitor Production Capacity Analysis
1.5.1 Global Antiretroviral Protease Inhibitor Total Production Capacity (2017-2028)
1.5.2 Global Antiretroviral Protease Inhibitor Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Antiretroviral Protease Inhibitor Market Drivers
1.6.2 Antiretroviral Protease Inhibitor Market Restraints
1.6.3 Antiretroviral Protease Inhibitor Trends Analysis
2 Manufacturers Profiles
2.1 Boehringer Ingelheim
2.1.1 Boehringer Ingelheim Details
2.1.2 Boehringer Ingelheim Major Business
2.1.3 Boehringer Ingelheim Antiretroviral Protease Inhibitor Product and Services
2.1.4 Boehringer Ingelheim Antiretroviral Protease Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Antiretroviral Protease Inhibitor Product and Services
2.2.4 Merck Antiretroviral Protease Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Genentech
2.3.1 Genentech Details
2.3.2 Genentech Major Business
2.3.3 Genentech Antiretroviral Protease Inhibitor Product and Services
2.3.4 Genentech Antiretroviral Protease Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 AbbVie
2.4.1 AbbVie Details
2.4.2 AbbVie Major Business
2.4.3 AbbVie Antiretroviral Protease Inhibitor Product and Services
2.4.4 AbbVie Antiretroviral Protease Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Tibotec
2.5.1 Tibotec Details
2.5.2 Tibotec Major Business
2.5.3 Tibotec Antiretroviral Protease Inhibitor Product and Services
2.5.4 Tibotec Antiretroviral Protease Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Bristol-Myers Squibb
2.6.1 Bristol-Myers Squibb Details
2.6.2 Bristol-Myers Squibb Major Business
2.6.3 Bristol-Myers Squibb Antiretroviral Protease Inhibitor Product and Services
2.6.4 Bristol-Myers Squibb Antiretroviral Protease Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Antiretroviral Protease Inhibitor Breakdown Data by Manufacturer
3.1 Global Antiretroviral Protease Inhibitor Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Antiretroviral Protease Inhibitor Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Antiretroviral Protease Inhibitor
3.4 Market Concentration Rate
3.4.1 Top 3 Antiretroviral Protease Inhibitor Manufacturer Market Share in 2021
3.4.2 Top 6 Antiretroviral Protease Inhibitor Manufacturer Market Share in 2021
3.5 Global Antiretroviral Protease Inhibitor Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Antiretroviral Protease Inhibitor Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Antiretroviral Protease Inhibitor Market Size by Region
4.1.1 Global Antiretroviral Protease Inhibitor Sales in Volume by Region (2017-2028)
4.1.2 Global Antiretroviral Protease Inhibitor Revenue by Region (2017-2028)
4.2 North America Antiretroviral Protease Inhibitor Revenue (2017-2028)
4.3 Europe Antiretroviral Protease Inhibitor Revenue (2017-2028)
4.4 Asia-Pacific Antiretroviral Protease Inhibitor Revenue (2017-2028)
4.5 South America Antiretroviral Protease Inhibitor Revenue (2017-2028)
4.6 Middle East and Africa Antiretroviral Protease Inhibitor Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Antiretroviral Protease Inhibitor Sales in Volume by Type (2017-2028)
5.2 Global Antiretroviral Protease Inhibitor Revenue by Type (2017-2028)
5.3 Global Antiretroviral Protease Inhibitor Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Antiretroviral Protease Inhibitor Sales in Volume by Application (2017-2028)
6.2 Global Antiretroviral Protease Inhibitor Revenue by Application (2017-2028)
6.3 Global Antiretroviral Protease Inhibitor Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Antiretroviral Protease Inhibitor Sales by Type (2017-2028)
7.2 North America Antiretroviral Protease Inhibitor Sales by Application (2017-2028)
7.3 North America Antiretroviral Protease Inhibitor Market Size by Country
7.3.1 North America Antiretroviral Protease Inhibitor Sales in Volume by Country (2017-2028)
7.3.2 North America Antiretroviral Protease Inhibitor Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Antiretroviral Protease Inhibitor Sales by Type (2017-2028)
8.2 Europe Antiretroviral Protease Inhibitor Sales by Application (2017-2028)
8.3 Europe Antiretroviral Protease Inhibitor Market Size by Country
8.3.1 Europe Antiretroviral Protease Inhibitor Sales in Volume by Country (2017-2028)
8.3.2 Europe Antiretroviral Protease Inhibitor Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Antiretroviral Protease Inhibitor Sales by Type (2017-2028)
9.2 Asia-Pacific Antiretroviral Protease Inhibitor Sales by Application (2017-2028)
9.3 Asia-Pacific Antiretroviral Protease Inhibitor Market Size by Region
9.3.1 Asia-Pacific Antiretroviral Protease Inhibitor Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Antiretroviral Protease Inhibitor Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Antiretroviral Protease Inhibitor Sales by Type (2017-2028)
10.2 South America Antiretroviral Protease Inhibitor Sales by Application (2017-2028)
10.3 South America Antiretroviral Protease Inhibitor Market Size by Country
10.3.1 South America Antiretroviral Protease Inhibitor Sales in Volume by Country (2017-2028)
10.3.2 South America Antiretroviral Protease Inhibitor Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Antiretroviral Protease Inhibitor Sales by Type (2017-2028)
11.2 Middle East & Africa Antiretroviral Protease Inhibitor Sales by Application (2017-2028)
11.3 Middle East & Africa Antiretroviral Protease Inhibitor Market Size by Country
11.3.1 Middle East & Africa Antiretroviral Protease Inhibitor Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Antiretroviral Protease Inhibitor Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Antiretroviral Protease Inhibitor and Key Manufacturers
12.2 Manufacturing Costs Percentage of Antiretroviral Protease Inhibitor
12.3 Antiretroviral Protease Inhibitor Production Process
12.4 Antiretroviral Protease Inhibitor Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Antiretroviral Protease Inhibitor Typical Distributors
13.3 Antiretroviral Protease Inhibitor Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Antiretroviral Protease Inhibitor Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Antiretroviral Protease Inhibitor Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 4. Boehringer Ingelheim Major Business
Table 5. Boehringer Ingelheim Antiretroviral Protease Inhibitor Product and Services
Table 6. Boehringer Ingelheim Antiretroviral Protease Inhibitor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Major Business
Table 9. Merck Antiretroviral Protease Inhibitor Product and Services
Table 10. Merck Antiretroviral Protease Inhibitor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Genentech Basic Information, Manufacturing Base and Competitors
Table 12. Genentech Major Business
Table 13. Genentech Antiretroviral Protease Inhibitor Product and Services
Table 14. Genentech Antiretroviral Protease Inhibitor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. AbbVie Basic Information, Manufacturing Base and Competitors
Table 16. AbbVie Major Business
Table 17. AbbVie Antiretroviral Protease Inhibitor Product and Services
Table 18. AbbVie Antiretroviral Protease Inhibitor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Tibotec Basic Information, Manufacturing Base and Competitors
Table 20. Tibotec Major Business
Table 21. Tibotec Antiretroviral Protease Inhibitor Product and Services
Table 22. Tibotec Antiretroviral Protease Inhibitor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 24. Bristol-Myers Squibb Major Business
Table 25. Bristol-Myers Squibb Antiretroviral Protease Inhibitor Product and Services
Table 26. Bristol-Myers Squibb Antiretroviral Protease Inhibitor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Global Antiretroviral Protease Inhibitor Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 28. Global Antiretroviral Protease Inhibitor Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 29. Market Position of Manufacturers in Antiretroviral Protease Inhibitor, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 30. Global Antiretroviral Protease Inhibitor Production Capacity by Company, (K Units): 2020 VS 2021
Table 31. Head Office and Antiretroviral Protease Inhibitor Production Site of Key Manufacturer
Table 32. Antiretroviral Protease Inhibitor New Entrant and Capacity Expansion Plans
Table 33. Antiretroviral Protease Inhibitor Mergers & Acquisitions in the Past Five Years
Table 34. Global Antiretroviral Protease Inhibitor Sales by Region (2017-2022) & (K Units)
Table 35. Global Antiretroviral Protease Inhibitor Sales by Region (2023-2028) & (K Units)
Table 36. Global Antiretroviral Protease Inhibitor Revenue by Region (2017-2022) & (USD Million)
Table 37. Global Antiretroviral Protease Inhibitor Revenue by Region (2023-2028) & (USD Million)
Table 38. Global Antiretroviral Protease Inhibitor Sales by Type (2017-2022) & (K Units)
Table 39. Global Antiretroviral Protease Inhibitor Sales by Type (2023-2028) & (K Units)
Table 40. Global Antiretroviral Protease Inhibitor Revenue by Type (2017-2022) & (USD Million)
Table 41. Global Antiretroviral Protease Inhibitor Revenue by Type (2023-2028) & (USD Million)
Table 42. Global Antiretroviral Protease Inhibitor Price by Type (2017-2022) & (US$/Unit)
Table 43. Global Antiretroviral Protease Inhibitor Price by Type (2023-2028) & (US$/Unit)
Table 44. Global Antiretroviral Protease Inhibitor Sales by Application (2017-2022) & (K Units)
Table 45. Global Antiretroviral Protease Inhibitor Sales by Application (2023-2028) & (K Units)
Table 46. Global Antiretroviral Protease Inhibitor Revenue by Application (2017-2022) & (USD Million)
Table 47. Global Antiretroviral Protease Inhibitor Revenue by Application (2023-2028) & (USD Million)
Table 48. Global Antiretroviral Protease Inhibitor Price by Application (2017-2022) & (US$/Unit)
Table 49. Global Antiretroviral Protease Inhibitor Price by Application (2023-2028) & (US$/Unit)
Table 50. North America Antiretroviral Protease Inhibitor Sales by Country (2017-2022) & (K Units)
Table 51. North America Antiretroviral Protease Inhibitor Sales by Country (2023-2028) & (K Units)
Table 52. North America Antiretroviral Protease Inhibitor Revenue by Country (2017-2022) & (USD Million)
Table 53. North America Antiretroviral Protease Inhibitor Revenue by Country (2023-2028) & (USD Million)
Table 54. North America Antiretroviral Protease Inhibitor Sales by Type (2017-2022) & (K Units)
Table 55. North America Antiretroviral Protease Inhibitor Sales by Type (2023-2028) & (K Units)
Table 56. North America Antiretroviral Protease Inhibitor Sales by Application (2017-2022) & (K Units)
Table 57. North America Antiretroviral Protease Inhibitor Sales by Application (2023-2028) & (K Units)
Table 58. Europe Antiretroviral Protease Inhibitor Sales by Country (2017-2022) & (K Units)
Table 59. Europe Antiretroviral Protease Inhibitor Sales by Country (2023-2028) & (K Units)
Table 60. Europe Antiretroviral Protease Inhibitor Revenue by Country (2017-2022) & (USD Million)
Table 61. Europe Antiretroviral Protease Inhibitor Revenue by Country (2023-2028) & (USD Million)
Table 62. Europe Antiretroviral Protease Inhibitor Sales by Type (2017-2022) & (K Units)
Table 63. Europe Antiretroviral Protease Inhibitor Sales by Type (2023-2028) & (K Units)
Table 64. Europe Antiretroviral Protease Inhibitor Sales by Application (2017-2022) & (K Units)
Table 65. Europe Antiretroviral Protease Inhibitor Sales by Application (2023-2028) & (K Units)
Table 66. Asia-Pacific Antiretroviral Protease Inhibitor Sales by Region (2017-2022) & (K Units)
Table 67. Asia-Pacific Antiretroviral Protease Inhibitor Sales by Region (2023-2028) & (K Units)
Table 68. Asia-Pacific Antiretroviral Protease Inhibitor Revenue by Region (2017-2022) & (USD Million)
Table 69. Asia-Pacific Antiretroviral Protease Inhibitor Revenue by Region (2023-2028) & (USD Million)
Table 70. Asia-Pacific Antiretroviral Protease Inhibitor Sales by Type (2017-2022) & (K Units)
Table 71. Asia-Pacific Antiretroviral Protease Inhibitor Sales by Type (2023-2028) & (K Units)
Table 72. Asia-Pacific Antiretroviral Protease Inhibitor Sales by Application (2017-2022) & (K Units)
Table 73. Asia-Pacific Antiretroviral Protease Inhibitor Sales by Application (2023-2028) & (K Units)
Table 74. South America Antiretroviral Protease Inhibitor Sales by Country (2017-2022) & (K Units)
Table 75. South America Antiretroviral Protease Inhibitor Sales by Country (2023-2028) & (K Units)
Table 76. South America Antiretroviral Protease Inhibitor Revenue by Country (2017-2022) & (USD Million)
Table 77. South America Antiretroviral Protease Inhibitor Revenue by Country (2023-2028) & (USD Million)
Table 78. South America Antiretroviral Protease Inhibitor Sales by Type (2017-2022) & (K Units)
Table 79. South America Antiretroviral Protease Inhibitor Sales by Type (2023-2028) & (K Units)
Table 80. South America Antiretroviral Protease Inhibitor Sales by Application (2017-2022) & (K Units)
Table 81. South America Antiretroviral Protease Inhibitor Sales by Application (2023-2028) & (K Units)
Table 82. Middle East & Africa Antiretroviral Protease Inhibitor Sales by Region (2017-2022) & (K Units)
Table 83. Middle East & Africa Antiretroviral Protease Inhibitor Sales by Region (2023-2028) & (K Units)
Table 84. Middle East & Africa Antiretroviral Protease Inhibitor Revenue by Region (2017-2022) & (USD Million)
Table 85. Middle East & Africa Antiretroviral Protease Inhibitor Revenue by Region (2023-2028) & (USD Million)
Table 86. Middle East & Africa Antiretroviral Protease Inhibitor Sales by Type (2017-2022) & (K Units)
Table 87. Middle East & Africa Antiretroviral Protease Inhibitor Sales by Type (2023-2028) & (K Units)
Table 88. Middle East & Africa Antiretroviral Protease Inhibitor Sales by Application (2017-2022) & (K Units)
Table 89. Middle East & Africa Antiretroviral Protease Inhibitor Sales by Application (2023-2028) & (K Units)
Table 90. Antiretroviral Protease Inhibitor Raw Material
Table 91. Key Manufacturers of Antiretroviral Protease Inhibitor Raw Materials
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Antiretroviral Protease Inhibitor Typical Distributors
Table 95. Antiretroviral Protease Inhibitor Typical Customers
List of Figures
Figure 1. Antiretroviral Protease Inhibitor Picture
Figure 2. Global Antiretroviral Protease Inhibitor Revenue Market Share by Type in 2021
Figure 3. Serine Protease Inhibitors
Figure 4. Cysteine Protease Inhibitors
Figure 5. Amino Peptidase Inhibitor
Figure 6. Aspartic Protease Inhibitors
Figure 7. Metallo-Protease Inhibitors
Figure 8. Others
Figure 9. Global Antiretroviral Protease Inhibitor Revenue Market Share by Application in 2021
Figure 10. Hospital Pharmacy
Figure 11. Retail Pharmacy
Figure 12. Online Pharmacy
Figure 13. Others
Figure 14. Global Antiretroviral Protease Inhibitor Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 15. Global Antiretroviral Protease Inhibitor Revenue and Forecast (2017-2028) & (USD Million)
Figure 16. Global Antiretroviral Protease Inhibitor Sales (2017-2028) & (K Units)
Figure 17. Global Antiretroviral Protease Inhibitor Price (2017-2028) & (US$/Unit)
Figure 18. Global Antiretroviral Protease Inhibitor Production Capacity (2017-2028) & (K Units)
Figure 19. Global Antiretroviral Protease Inhibitor Production Capacity by Geographic Region: 2022 VS 2028
Figure 20. Antiretroviral Protease Inhibitor Market Drivers
Figure 21. Antiretroviral Protease Inhibitor Market Restraints
Figure 22. Antiretroviral Protease Inhibitor Market Trends
Figure 23. Global Antiretroviral Protease Inhibitor Sales Market Share by Manufacturer in 2021
Figure 24. Global Antiretroviral Protease Inhibitor Revenue Market Share by Manufacturer in 2021
Figure 25. Antiretroviral Protease Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 26. Top 3 Antiretroviral Protease Inhibitor Manufacturer (Revenue) Market Share in 2021
Figure 27. Top 6 Antiretroviral Protease Inhibitor Manufacturer (Revenue) Market Share in 2021
Figure 28. Global Antiretroviral Protease Inhibitor Sales Market Share by Region (2017-2028)
Figure 29. Global Antiretroviral Protease Inhibitor Revenue Market Share by Region (2017-2028)
Figure 30. North America Antiretroviral Protease Inhibitor Revenue (2017-2028) & (USD Million)
Figure 31. Europe Antiretroviral Protease Inhibitor Revenue (2017-2028) & (USD Million)
Figure 32. Asia-Pacific Antiretroviral Protease Inhibitor Revenue (2017-2028) & (USD Million)
Figure 33. South America Antiretroviral Protease Inhibitor Revenue (2017-2028) & (USD Million)
Figure 34. Middle East & Africa Antiretroviral Protease Inhibitor Revenue (2017-2028) & (USD Million)
Figure 35. Global Antiretroviral Protease Inhibitor Sales Market Share by Type (2017-2028)
Figure 36. Global Antiretroviral Protease Inhibitor Revenue Market Share by Type (2017-2028)
Figure 37. Global Antiretroviral Protease Inhibitor Price by Type (2017-2028) & (US$/Unit)
Figure 38. Global Antiretroviral Protease Inhibitor Sales Market Share by Application (2017-2028)
Figure 39. Global Antiretroviral Protease Inhibitor Revenue Market Share by Application (2017-2028)
Figure 40. Global Antiretroviral Protease Inhibitor Price by Application (2017-2028) & (US$/Unit)
Figure 41. North America Antiretroviral Protease Inhibitor Sales Market Share by Type (2017-2028)
Figure 42. North America Antiretroviral Protease Inhibitor Sales Market Share by Application (2017-2028)
Figure 43. North America Antiretroviral Protease Inhibitor Sales Market Share by Country (2017-2028)
Figure 44. North America Antiretroviral Protease Inhibitor Revenue Market Share by Country (2017-2028)
Figure 45. United States Antiretroviral Protease Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Canada Antiretroviral Protease Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Mexico Antiretroviral Protease Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Europe Antiretroviral Protease Inhibitor Sales Market Share by Type (2017-2028)
Figure 49. Europe Antiretroviral Protease Inhibitor Sales Market Share by Application (2017-2028)
Figure 50. Europe Antiretroviral Protease Inhibitor Sales Market Share by Country (2017-2028)
Figure 51. Europe Antiretroviral Protease Inhibitor Revenue Market Share by Country (2017-2028)
Figure 52. Germany Antiretroviral Protease Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. France Antiretroviral Protease Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. United Kingdom Antiretroviral Protease Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Russia Antiretroviral Protease Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Italy Antiretroviral Protease Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Asia-Pacific Antiretroviral Protease Inhibitor Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Antiretroviral Protease Inhibitor Sales Market Share by Application (2017-2028)
Figure 59. Asia-Pacific Antiretroviral Protease Inhibitor Sales Market Share by Region (2017-2028)
Figure 60. Asia-Pacific Antiretroviral Protease Inhibitor Revenue Market Share by Region (2017-2028)
Figure 61. China Antiretroviral Protease Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Japan Antiretroviral Protease Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Korea Antiretroviral Protease Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. India Antiretroviral Protease Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Southeast Asia Antiretroviral Protease Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Australia Antiretroviral Protease Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South America Antiretroviral Protease Inhibitor Sales Market Share by Type (2017-2028)
Figure 68. South America Antiretroviral Protease Inhibitor Sales Market Share by Application (2017-2028)
Figure 69. South America Antiretroviral Protease Inhibitor Sales Market Share by Country (2017-2028)
Figure 70. South America Antiretroviral Protease Inhibitor Revenue Market Share by Country (2017-2028)
Figure 71. Brazil Antiretroviral Protease Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Argentina Antiretroviral Protease Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Middle East & Africa Antiretroviral Protease Inhibitor Sales Market Share by Type (2017-2028)
Figure 74. Middle East & Africa Antiretroviral Protease Inhibitor Sales Market Share by Application (2017-2028)
Figure 75. Middle East & Africa Antiretroviral Protease Inhibitor Sales Market Share by Region (2017-2028)
Figure 76. Middle East & Africa Antiretroviral Protease Inhibitor Revenue Market Share by Region (2017-2028)
Figure 77. Turkey Antiretroviral Protease Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Egypt Antiretroviral Protease Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Saudi Arabia Antiretroviral Protease Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. South Africa Antiretroviral Protease Inhibitor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Manufacturing Cost Structure Analysis of Antiretroviral Protease Inhibitor in 2021
Figure 82. Manufacturing Process Analysis of Antiretroviral Protease Inhibitor
Figure 83. Antiretroviral Protease Inhibitor Industrial Chain
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
Figure 85. Methodology
Figure 86. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の3CLプロテアーゼ阻害剤市場2022年：市場規模予測（～2028年）
  • 世界の3CLプロテアーゼアッセイキット市場2022年：市場規模予測（～2028年）
  • 世界のセリンプロテアーゼ市場2022年：市場規模予測（～2028年）
  • 世界のCDK4及び6阻害医薬品市場2022年：市場規模予測（～2028年）
  • 世界のプラスミノーゲンアクチベーターインヒビター1市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19151 )"世界の抗レトロウイルスプロテアーゼ阻害剤市場2022年：市場規模予測（～2028年）" (英文：Global Antiretroviral Protease Inhibitor Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。